Is this Gilead's next acquisition target? https://endpts.com/is-gilead-chief-dan-oday-ready-for-a-new-bolt-on-biotech-buyout-in-the-oncology-field/
Is Gilead chief Dan O’Day ready for a new biotech deal in the oncology field?
Twitter lit up Wednesday afternoon after Bloomberg put out a story that a deal-hungry Gilead was in the hunt to buy a stake in Arcus Biosciences — one of the up-and-comers in immuno-oncology that recently aligned itself with O’Day’s alma mater Roche. The biotech’s stock $RCUS instantly jumped 51% after